$104.80
$0.00 (0.00%)
End-of-day quote: 08/12/2022
NYSE:EW

Edwards Lifesciences (EW)

Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally.

If you are interested in EW stock information, you might also be interested in competitors like TSX:NVCN.

With a P/E ratio of 20.64, the stock appears relatively expensive compared to its index ^SPX at the moment.

The market capitalization of Edwards Lifesciences is currently at $64.97 B. This places it among the high capitalized companies.

The book value reported in the balance sheet results in a P/B ratio of 10.93.

With one share of Edwards Lifesciences investors achieved a dividend of $0.00. This results in a very low dividend yield of 0.00%.

For the risk analysis, the high beta factor should be noted, which is currently at a value of 1.12. The price of the stock NYSE:EW is therefore subject to relatively strong fluctuations in relation to the overall market.

0.91% of EW Stocks is owned by insiders.

For Wall Street analysts, a price target of $127.85 is currently considered realistic.

NYSE:EW has a 52 week range of $85.58 - $131.73 and is currently trading around $104.80.

The low short sale ratio indicated that the value might increase in the foreseeable future.

5
Neutral
1
2
3
4
5
6
7
8
9
10
1M 3M YTD 1Y 2Y 5Y 10Y 20Y
P/E Ratio
41.1
Market Cap
64.97B
LT Debt/Cap
0.01%
Price-to-book Ratio
10.93
Earnings
10/28/2022
Dividend
$0.00
Div Yld
0.00%
Dividend Growth
0 Years
Beta
1.12
Short Interest
0.89%
Forecast 1Y
0.22%
Analyst Price Target
$127.85
LTG 5Y
18.25%
52 week range
$85.58 - $131.73